S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TSHA Taysha Gene Therapies Inc

1.8511

0.0011 (0.06%)

Last Updated: 14:21:31

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Taysha Gene Therapies Charts.

Taysha Gene Therapies Inc News

Form EFFECT - Notice of Effectiveness
Sunday 22 December 2024 (4 days ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Friday 13 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 6 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Wednesday 13 November 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13
Wednesday 6 November 2024 (2 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 1 November 2024 (2 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
Tuesday 22 October 2024 (2 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 4 October 2024 (3 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress
Thursday 26 September 2024 (3 months ago) • GlobeNewswire Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Friday 6 September 2024 (4 months ago) • GlobeNewswire Inc.

More Taysha Gene Therapies Inc News Articles

Information Services

Bmo Monthly Dividend Fun...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions